Evidence map›Paper›PMID 16940873›Full record

ReviewCurrent opinion in infectious diseases2006

Microsporidiosis: current status.

Elizabeth S Didier, Louis M Weiss

Abstract readReview
In one paragraph

Review in Current opinion in infectious diseases, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 191 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
191citing papers in PubMed, 2 pooled it
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

191 citing papers in PubMed, 2 syntheses or guidelines pooled it, 390 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Article
  4. A New Host-Parasite Association: ALife (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Waterborne protozoan and microsporidian parasites in Eurasian beavers (International journal for parasitology. Parasites and wildlife · 2025
    Article
  14. Chemical disinfection ofFrontiers in microbiology · 2025
    Article
  15. Emerging microbes & infections · 2024
    Review
  16. Article
  17. Identification ofOpen forum infectious diseases · 2024
    Article
  18. Investigation of the Infection ofVeterinary sciences · 2024
    Article
  19. Molecular Detection ofMicroorganisms · 2024
    Article
  20. Microorganisms · 2024
    Article

131 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Elizabeth S DidierDivision of Microbiology, Tulane National Primate Research Center, Covington, Louisiana 70433, USA. esdnda@tulane.edu
Louis M Weiss
Albert Einstein College of Medicine · USTulane University · US

Funding

ZCM:A NOVEL BROAD-SPECTRUM MICROBICIDE FOR SEXUALLY TRANSMITTED INFECTIONSP51RR000164 · NCRR · TULANE UNIVERSITY OF LOUISIANA · PI VEAZEY, RONALD S. · 1985 to 2011
$100.1M
New Opportunistic Infections in AIDS MicrosporidosisR01AI031788 · NIAID · YESHIVA UNIVERSITY · PI WEISS, LOUIS M. · 1992 to 2011
$4.6M
MICROSPORIDIOSIS IN AIDSR01AI039968 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI DIDIER, ELIZABETH SCHMIDT · 1996 to 2004
$855k
PRECLINICAL EVAL. OF THERAPIES FOR MICROSPORIDIAL INFECTN01AI075327 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI DIDIER, ELIZABETH SCHMIDT · 1997 to 2000
$398k
NCRR NIH HHS P51 RR000164NCRR NIH HHS RR00164NIAID NIH HHS AI31788NIAID NIH HHS AI39968NIAID NIH HHS AI75327NIAID NIH HHS R01 AI031788NIAID NIH HHS R01 AI039968
6 · The paper itself

Abstract

purpose of reviewMicrosporidiosis is an emerging and opportunistic infection associated with a wide range of clinical syndromes in humans. This review highlights the research on microsporidiosis in humans during the previous 2 years. RECENT

findingsThe reduced and compact microsporidian genome has generated much interest for better understanding the evolution of these parasites, and comparative molecular phylogenetic studies continue to support a relationship between the microsporidia and fungi. Through increased awareness and improved diagnostics, microsporidiosis has been identified in a broader range of human populations that, in addition to persons with HIV infection, includes travelers, children, organ transplant recipients, and the elderly. SUMMARY: Effective commercial therapies for Enterocytozoon bieneusi, the most common microsporidian species identified in humans, are still lacking, making the need to develop tissue culture and small animal models increasingly urgent. Environmental transport modeling and disinfection strategies are being addressed for improving water safety. Questions still exist about whether microsporidia infections remain persistent in asymptomatic immune-competent individuals, reactivate during conditions of immune compromise, or may be transmitted to others at risk, such as during pregnancy or through organ donation. Reliable serological diagnostic methods are needed to supplement polymerase chain reaction or histochemistry when spore shedding may be sporadic.

Indexed as

MicrosporidiaAnimalsHumansMicrosporidiosis

Identifiers

PMID16940873
PMCPMC3109650
OpenAlexW2001748299

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.